ABOS·00509G209·US·equity·Healthcare - Biotechnology-Activist
ABOS (ACUMEN PHARMACEUTICALS INC) is held by 49 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($49.5M), Alyeska Investment Group, L.P. ($5.8M), FRANKLIN RESOURCES INC ($5.4M). Net institutional sentiment: Bullish.
See how ABOS's score breaks down across 4 SEC sources
Showing 1-20 of 54
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer